Neil Thierry
Child & Adolescent Psychiatry · Tampa, FLNPI 1548271596
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,850, more than ten times the $133 reported in 2019.
Across 242 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$830
- Teva Pharmaceuticals USA, Inc.$473
- Alkermes, Inc.$416
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$334
- Neurocrine Biosciences, Inc.$298
- Otsuka America Pharmaceutical, Inc.$295
- plus $1K from 9 others
What the payments were for
- Food & beverage$3,710100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 76 | $830 |
| Teva Pharmaceuticals USA, Inc. | 40 | $473 |
| Alkermes, Inc. | 25 | $416 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $334 |
| Neurocrine Biosciences, Inc. | 12 | $298 |
| Otsuka America Pharmaceutical, Inc. | 19 | $295 |
| E.r. Squibb & Sons, L.L.C. | 12 | $240 |
| AbbVie | 16 | $226 |
| Johnson & Johnson | 8 | $188 |
| Tris Pharma Inc | 3 | $144 |
| Indivior Inc. | 4 | $97 |
| Vanda Pharmaceuticals Inc. | 4 | $83 |
| Supernus Pharmaceuticals, Inc. | 4 | $70 |
| Neuronetics, Inc. | 1 | $11 |
| Corium, LLC | 2 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,710 in reported general payments places this provider in the 80th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 15 | $607 |
| Benztropine Mesylate | 24 | $470 |
| Hydroxyzine Pamoate | 19 | $361 |
| Risperidone | 18 | $278 |
| Haloperidol | 17 | $271 |
| Quetiapine Fumarate | 15 | $239 |
| Lurasidone Hcl | 13 | $217 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $157 |
| Bupropion XlBupropion Hcl | 14 | $145 |
| Sertraline Hcl | 18 | $138 |
| Fluoxetine Hcl | 18 | $126 |
| Trazodone Hcl | 18 | $52 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Tampa
- Vashaun WilliamsTampa$5K
- Megan ToufexisTampa$4K
- Reena ThomasTampa$4K
- Leigh RuthTampa$3K
- Saundra StockTampa$2K
- Phyllis FeldmanTampa$2K
- Craig KuninsGulfport$265K
- Elias SarkisGainesville$169K
- Jeffrey AlvaroSt Petersburg$87K
- Rosa Negron MunozLakeland$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.